Intuitive Surgical, Inc.

NASDAQ:ISRG

Medical - Devices

Healthcare
$420.95 +0.91%

+$3.65 today

Market cap
$145.92B
Beta
1.45
P/E (TTM)
48.3
EPS (TTM)
$8.39
52W Low $396.68High $603.88

Volume 2.20M

Average 2.21M

ISRG EBITDA Margin

EBITDA as a percentage of revenue.

Intuitive Surgical, Inc.NASDAQ: ISRG

EBITDA Margin · Q3 FY2026 · quarter ended Sep 2026

EBITDA Margin narrows to 21.9%

EBITDA Margin was 21.9% in Q3 FY2026, down 18.6 pp from a year earlier. On a trailing-twelve-month basis it was 36.2%, down 2.8 pp year over year. Over 3 fiscal years it widened by 7.9 pp.

Context

  • EBITDA Margin widened in 3 of the last 3 fiscal years.
  • FY2025 was the highest level in the 4 fiscal years shown.

What to watch

Whether EBITDA Margin reaches the consensus estimate from 24 analysts of 45.6% for the fiscal year ending Dec 2026, up from 39.6% in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterSep 2026
21.9%-19.8 pp QoQ
Last fiscal yearDec 2025
39.6%+2.1 pp YoY
LTMSep 2026
36.2%-2.8 pp YoY
EBITDA Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter-18.6 pp+3.0 pp+21.6 pp
1 year+2.1 pp+6.0 pp+3.9 pp
3 years+7.9 pp+4.5 pp-3.4 pp
5 years+5.9 pp—
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EBITDA Margin history

Percent of revenue · from the income statement

Latest · FY2025
39.6%
Year-over-year change
+2.1pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EBITDA Margin vs competitors

How ISRG compares with its peers on the latest reported figures

  • ISRG's LTM Sep 2026 EBITDA Margin of 36.2% is the highest of the 5 companies compared; the peer median is 17.0%.
  • Its year-over-year change of -2.8 pp is the 3rd highest of 4, against a peer median of -1.3 pp.
  • Over three fiscal years its change of +7.9 pp compares with a peer median of +3.4 pp.
ISRG Competitors Peer median
EBITDA Margin for ISRG and competitors
Company Period LTM level YoY 3-year change
ISRGIntuitive Surgical, Inc.LTM Sep 202636.2% -2.8 pp+7.9 pp
SYKStryker CorporationLTM Jun 202625.9% +5.9 pp+3.4 pp
SNNSmith & Nephew plcFY202521.7% -1.3 pp-0.4 pp
CNMDCONMED CorporationLTM Mar 202612.4% -6.5 pp+10.5 pp
MBOTMicrobot Medical Inc.LTM Mar 2026-13493.3% ——
Peer median (excluding ISRG) 17.0%-1.3 pp+3.4 pp

Competitors are the stored peer set for ISRG. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue5.71B6.22B7.12B8.35B10.06B
Cost of Revenue1.75B2.03B2.39B2.72B3.42B
Gross Profit3.96B4.2B4.73B5.63B6.64B
Gross Margin69.3%67.4%66.4%67.5%66.0%
Research & Development671M879M998.8M1.15B1.31B
Selling, General & Admin1.47B1.74B1.96B2.14B2.39B
Operating Expenses2.14B2.62B2.96B3.29B3.7B
Depreciation & Amortization310.2M365.8M454.8M462M677.1M
EBITDA2.2B1.97B2.41B3.14B3.99B
EBITDA Margin38.5%31.7%33.9%37.5%39.6%
Operating Income1.82B1.58B1.77B2.35B2.95B
Operating Margin31.9%25.3%24.8%28.1%29.3%
Interest Income69.3M29.7M192.1M324.9M365.9M
Interest Expense00000
Other Income / Expenses69.3M29.7M192.1M324.9M365.9M
Income Before Tax1.89B1.61B1.96B2.67B3.31B
Pre-Tax Margin33.1%25.8%27.5%32.0%32.9%
Income Tax Expense162.2M262.4M141.6M336.3M434.8M
Net Income1.7B1.32B1.8B2.32B2.86B
Net Margin29.9%21.3%25.2%27.8%28.4%
EPS (Basic)4.793.725.126.548.00
EPS (Diluted)4.663.655.036.427.87
Weighted Avg Shares356.1M355.7M351.2M355.2M356.9M
Weighted Avg Shares (Diluted)365.8M362M357.4M362M362.7M

Intuitive Surgical, Inc.

NASDAQ:ISRG

Intrinsic Alpha fair value

Locked

Current Price

$420.95

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.